ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

President’s FY 1992 Budget Seeks $1.81 Billion For NCI, 5.6% Increase, But $800M Below Byspass

February 8, 1991

Patient’s Husband Had Idea to Use Avastin For Glioblastoma

April 3, 2009

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989

CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments

April 6, 1990

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014